mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.21 |
0.001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.001 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.001 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |